1. Home
  2. VKTX vs MGRC Comparison

VKTX vs MGRC Comparison

Compare VKTX & MGRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • MGRC
  • Stock Information
  • Founded
  • VKTX 2012
  • MGRC 1979
  • Country
  • VKTX United States
  • MGRC United States
  • Employees
  • VKTX N/A
  • MGRC N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • MGRC Diversified Commercial Services
  • Sector
  • VKTX Health Care
  • MGRC Consumer Discretionary
  • Exchange
  • VKTX Nasdaq
  • MGRC Nasdaq
  • Market Cap
  • VKTX 2.8B
  • MGRC 2.8B
  • IPO Year
  • VKTX 2015
  • MGRC N/A
  • Fundamental
  • Price
  • VKTX $28.14
  • MGRC $120.74
  • Analyst Decision
  • VKTX Buy
  • MGRC Buy
  • Analyst Count
  • VKTX 12
  • MGRC 2
  • Target Price
  • VKTX $84.00
  • MGRC $145.50
  • AVG Volume (30 Days)
  • VKTX 3.9M
  • MGRC 171.6K
  • Earning Date
  • VKTX 07-23-2025
  • MGRC 07-24-2025
  • Dividend Yield
  • VKTX N/A
  • MGRC 1.61%
  • EPS Growth
  • VKTX N/A
  • MGRC 88.16
  • EPS
  • VKTX N/A
  • MGRC 9.65
  • Revenue
  • VKTX N/A
  • MGRC $918,531,000.00
  • Revenue This Year
  • VKTX N/A
  • MGRC $6.11
  • Revenue Next Year
  • VKTX N/A
  • MGRC $5.52
  • P/E Ratio
  • VKTX N/A
  • MGRC $12.52
  • Revenue Growth
  • VKTX N/A
  • MGRC 7.31
  • 52 Week Low
  • VKTX $18.92
  • MGRC $95.50
  • 52 Week High
  • VKTX $81.73
  • MGRC $129.93
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 55.39
  • MGRC 62.57
  • Support Level
  • VKTX $25.80
  • MGRC $114.66
  • Resistance Level
  • VKTX $28.80
  • MGRC $116.33
  • Average True Range (ATR)
  • VKTX 1.65
  • MGRC 3.02
  • MACD
  • VKTX 0.11
  • MGRC 0.57
  • Stochastic Oscillator
  • VKTX 86.93
  • MGRC 86.86

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About MGRC McGrath RentCorp

McGrath RentCorp is a rental company. It is comprised of four reportable business segments namely Modular building segment (Mobile Modular); Portable storage container segment (Portable Storage); Electronic test equipment segment (TRS-RenTelco); and its classroom manufacturing business selling modular buildings used primarily as classrooms in California (Enviroplex). The company generates its revenues majorily from the rental of its equipment on operating leases with sales of equipment occurring in the normal course of business.

Share on Social Networks: